Piramal Enterprises announces sale of BST-CarGel

By: | Published: January 13, 2016 9:07 AM

The company, however, did not disclose the value of transaction.

Piramal Enterprises today announced sale of BST-CarGel from Piramal Healthcare (Canada) Ltd to Smith & Nephew, a global medical technology business.

Through this transaction, an affiliate of Smith & Nephew plc will acquire ownership of all product and intellectual property assets related to BST-CarGel, a company statement said here.

The company, however, did not disclose the value of transaction.

BST-CarGel is a first-line cartilage repair product used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears.

The transaction does not have a material impact on the financials of PEL, the release said.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition